Sanders Morris Harris LLC lessened its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 64.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,399 shares of the company's stock after selling 6,116 shares during the period. Sanders Morris Harris LLC's holdings in Procter & Gamble were worth $542,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in the company. Nova Wealth Management Inc. bought a new stake in Procter & Gamble during the 1st quarter valued at $26,000. Signature Resources Capital Management LLC grew its holdings in shares of Procter & Gamble by 67.9% during the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock valued at $28,000 after buying an additional 72 shares during the last quarter. Quarry LP bought a new stake in shares of Procter & Gamble during the first quarter worth about $33,000. Mid American Wealth Advisory Group Inc. acquired a new stake in shares of Procter & Gamble in the 2nd quarter worth about $34,000. Finally, RMG Wealth Management LLC acquired a new position in Procter & Gamble during the 2nd quarter valued at about $37,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Price Performance
PG opened at $151.98 on Tuesday. The company has a market capitalization of $355.72 billion, a price-to-earnings ratio of 23.35, a PEG ratio of 4.02 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The firm has a 50-day moving average price of $154.86 and a 200-day moving average price of $158.59. Procter & Gamble Company has a twelve month low of $146.96 and a twelve month high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same period in the previous year, the business earned $1.40 EPS. Procter & Gamble's revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Friday, October 24th. Procter & Gamble's dividend payout ratio (DPR) is 64.82%.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the company. BNP Paribas Exane decreased their price target on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a report on Tuesday, September 23rd. JPMorgan Chase & Co. decreased their price objective on shares of Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating for the company in a research note on Friday, October 10th. Barclays dropped their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a research report on Wednesday, October 1st. Wells Fargo & Company dropped their price target on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a report on Thursday, September 25th. Finally, Evercore ISI reaffirmed an "in-line" rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $171.68.
Check Out Our Latest Analysis on PG
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO Jennifer L. Davis sold 3,227 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the sale, the chief executive officer directly owned 61,764 shares in the company, valued at $9,402,333.72. This represents a 4.97% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 490 shares of the company's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the completion of the transaction, the insider directly owned 12,616 shares in the company, valued at approximately $1,920,533.68. The trade was a 3.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock worth $23,421,279 in the last ninety days. Insiders own 0.20% of the company's stock.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.